Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
Department of Neuroscience and Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 51 Newton Rd., 2-248 BSB, Iowa City, IA 52242, USA.
Cardiovasc Res. 2021 Jan 1;117(1):308-319. doi: 10.1093/cvr/cvaa147.
Salt-sensitive (SS) hypertension is accompanied by impaired vasodilation in the systemic and renal circulation. However, the causal relationship between vascular dysfunction and salt-induced hypertension remains controversial. We sought to determine whether primary vascular dysfunction, characterized by a failure to vasodilate during salt loading, plays a causal role in the pathogenesis of SS hypertension.
Mice selectively expressing a peroxisome proliferator-activated receptor γ dominant-negative mutation in vascular smooth muscle (S-P467L) exhibited progressive SS hypertension during a 4 week high salt diet (HSD). This was associated with severely impaired vasodilation in systemic and renal vessels. Salt-induced impairment of vasodilation occurred as early as 3 days after HSD, which preceded the onset of SS hypertension. Notably, the overt salt-induced hypertension in S-P467L mice was not driven by higher cardiac output, implying elevations in peripheral vascular resistance. In keeping with this, HSD-fed S-P467L mice exhibited decreased smooth muscle responsiveness to nitric oxide (NO) in systemic vessels. HSD-fed S-P467L mice also exhibited elevated albuminuria and a blunted increase in urinary NO metabolites which was associated with blunted renal blood flow and increased sodium retention mediated by a lack of HSD-induced suppression of NKCC2. Blocking NKCC2 function prevented the salt-induced increase in blood pressure in S-P467L mice.
We conclude that failure to vasodilate in response to salt loading causes SS hypertension by restricting renal perfusion and reducing renal NO through a mechanism involving NKCC2 in a mouse model of vascular peroxisome proliferator-activated receptor γ impairment.
盐敏感(SS)高血压伴有全身和肾循环血管舒张功能障碍。然而,血管功能障碍与盐诱导高血压之间的因果关系仍存在争议。我们试图确定主要的血管功能障碍,即在盐负荷期间血管舒张功能丧失,是否在 SS 高血压的发病机制中起因果作用。
在 4 周高盐饮食(HSD)期间,血管平滑肌中过氧化物酶体增殖物激活受体 γ 显性负突变(S-P467L)选择性表达的小鼠表现出进行性 SS 高血压。这与全身和肾血管舒张严重受损有关。盐诱导的血管舒张功能障碍早在 HSD 后 3 天就发生了,早于 SS 高血压的发生。值得注意的是,S-P467L 小鼠明显的盐诱导性高血压不是由更高的心输出量引起的,这意味着外周血管阻力增加。与此一致的是,HSD 喂养的 S-P467L 小鼠全身血管对一氧化氮(NO)的平滑肌反应性降低。HSD 喂养的 S-P467L 小鼠还表现出白蛋白尿增加和尿 NO 代谢物增加减少,这与肾血流量减少和肾脏钠潴留增加有关,这是由 NKCC2 缺乏导致的 HSD 诱导抑制作用减弱引起的。阻断 NKCC2 功能可防止 S-P467L 小鼠的盐诱导性血压升高。
我们得出结论,盐负荷时血管舒张功能丧失通过限制肾灌注和减少肾 NO 通过一种涉及 NKCC2 的机制导致 SS 高血压,在血管过氧化物酶体增殖物激活受体 γ 损伤的小鼠模型中。